Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 57.0B | 67.5B | 62.6B | 58.7B |
Cost of revenue | 30.6B | 36.2B | 33.4B | 31.1B |
Gross profit | 26.4B | 31.3B | 29.2B | 27.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 18.6B | 20.3B | 19.2B | 17.9B |
Other operating expenses | — | 668.5M | 118.2M | 258.3M |
Operating income | 7.8B | 10.3B | 9.9B | 9.4B |
Non operating interest income | ||||
Income | 433.6M | 793.9M | 416.3M | 432.2M |
Expense | 911.3M | 995.4M | 901.1M | 1.0B |
Other income expense | — | — | — | — |
Pretax income | 7.4B | 9.6B | 9.3B | 9.5B |
Tax provision | 2.4B | 3.1B | 3.1B | 3.0B |
Net income | 5.0B | 6.5B | 6.2B | 6.5B |
Basic EPS | 11.8 | 11.5 | 11.0 | 10.7 |
Diluted EPS | 11.8 | 11.5 | 11.0 | 10.7 |
Basic average shares | 1.7B | 1.7B | 1.7B | 1.7B |
Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
EBITDA | 10.8B | 13.2B | 12.6B | 12.7B |
Net income from continuing op. | 5.0B | 6.5B | 6.2B | 6.5B |
Minority interests | -901.7M | -1.3B | -1.1B | -1.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |